General Information of the Protein
Protein ID
PT01199
Protein Name
Neuromedin-K receptor
Secondarily
Protein Name
NK-3 receptor
Neurokinin B receptor
Tachykinin receptor 3
Gene Name
TACR3
Secondarily
Gene Name
NK3R
TAC3R
Sequence
MATLPAAETWIDGGGGVGADAVNLTASLAAGAATGAVETGWLQLLDQAGNLSSSPSALGLPVASPAPSQPWANLTNQFVQPSWRIALWSLAYGVVVAVAVLGNLIVIWIILAHKRMRTVTNYFLVNLAFSDASMAAFNTLVNFIYALHSEWYFGANYCRFQNFFPITAVFASIYSMTAIAVDRYMAIIDPLKPRLSATATKIVIGSIWILAFLLAFPQCLYSKTKVMPGRTLCFVQWPEGPKQHFTYHIIVIILVYCFPLLIMGITYTIVGITLWGGEIPGDTCDKYHEQLKAKRKVVKMMIIVVMTFAICWLPYHIYFILTAIYQQLNRWKYIQQVYLASFWLAMSSTMYNPIIYCCLNKRFRAGFKRAFRWCPFIKVSSYDELELKTTRFHPNRQSSMYTVTRMESMTVVFDPNDADTTRSSRKKRATPRDPSFNGCSRRNSKSASATSSFISSPYTSVDEYS
    Show/Hide
Organism
Homo sapiens, Human
Protein Classification
Membrane receptor
>
Family A G protein-coupled receptor
>
Peptide receptor (family A GPCR)
>
Short peptide receptor (family A GPCR)
>
Neurokinin receptor
Function
This is a receptor for the tachykinin neuropeptide neuromedin-K (neurokinin B). It is associated with G proteins that activate a phosphatidylinositol-calcium second messenger system. The rank order of affinity of this receptor to tachykinins is: neuromedin-K > substance K > substance P.
    Show/Hide
Uniprot ID
Primary ID:
P29371

Secondarily ID:
Q0P510
    Show/Hide
Ensembl ID
ENSG00000169836
HGNC ID
HGNC:11528
Subcellular Location
Cell membrane
Map of Molecular Bioactivity Related to the Protein
Map of Molecular Bioactivity Related to the Protein

Protein
Cell Line
Compound

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Protein
Cell Line ID: CL000051 , BHK-21
Compound ID Compound Name Compound Formula
CP0426334
methyl N-[1-[[(1R,2S)-2-[benzyl(methyl)carbamoyl]-2-(3,4-dichlorophenyl)cyclopropyl]methyl]-4-phenylpiperidin-4-yl]carbamate
   Show/Hide
C32H35Cl2N3O3
 1
1
Ki = 1.5 nM
   TI
   LI
   LO
   TS
CP0512756
(1S,2R)-1-(3,4-dichlorophenyl)-N-(4-fluorobenzyl)-N-methyl-2-((4-(2-oxo-2-(pyrrolidin-1-yl)ethyl)piperazin-1-yl)methyl)cyclopropanecarboxamide
   Show/Hide
C29H35Cl2FN4O2
 1
1
Ki = 1.8 nM
   TI
   LI
   LO
   TS
CP0489233
(1S,2R)-1-(3,4-dichlorophenyl)-2-((3-(4-(N,N-dimethylsulfamoyl)piperazin-1-yl)azetidin-1-yl)methyl)-N-(4-fluorobenzyl)-N-methylcyclopropanecarboxamide
   Show/Hide
C28H36Cl2FN5O3S
 1
1
Ki = 1.9 nM
   TI
   LI
   LO
   TS
CP0426335
(1S,2R)-N-benzyl-1-(3,4-dichlorophenyl)-2-((4-(3,3-dimethylureido)-4-phenylpiperidin-1-yl)methyl)-N-methylcyclopropanecarboxamide
   Show/Hide
C33H38Cl2N4O2
 1
1
Ki = 2.8 nM
   TI
   LI
   LO
   TS
CP0516565
(1S,2R)-1-(3,4-dichlorophenyl)-N-(4-fluorobenzyl)-N-methyl-2-((4-(2-morpholinoacetyl)piperazin-1-yl)methyl)cyclopropanecarboxamide
   Show/Hide
C29H35Cl2FN4O3
 1
1
Ki = 3.3 nM
   TI
   LI
   LO
   TS
CP0513054
N'-[1-[[(1R,2S)-2-[benzyl(methyl)carbamoyl]-2-(3,4-dichlorophenyl)cyclopropyl]methyl]-4-phenylpiperidin-4-yl]-N'-methyloxamide
   Show/Hide
C33H36Cl2N4O3
 1
1
Ki = 3.6 nM
   TI
   LI
   LO
   TS
CP0426336
(1S,2R)-1-(3,4-dichlorophenyl)-N-(4-fluorobenzyl)-N-methyl-2-((4-(2-morpholinoethyl)piperazin-1-yl)methyl)cyclopropanecarboxamide
   Show/Hide
C29H37Cl2FN4O2
 1
1
Ki = 3.7 nM
   TI
   LI
   LO
   TS
CP0498917
(1S,2R)-N-benzyl-1-(3,4-dichlorophenyl)-N-methyl-2-((4-(N-methylacetamido)-4-phenylpiperidin-1-yl)methyl)cyclopropanecarboxamide
   Show/Hide
C33H37Cl2N3O2
 1
1
Ki = 4.2 nM
   TI
   LI
   LO
   TS
CP0489226
2-[(4-acetamido-4-phenylpiperidin-1-yl)methyl]-1-(3,4-dichlorophenyl)-N-methyl-N-[[4-(trifluoromethyl)phenyl]methyl]cyclopropane-1-carboxamide
   Show/Hide
C33H34Cl2F3N3O2
 1
1
Ki = 4.6 nM
   TI
   LI
   LO
   TS
CP0489224
2-[(4-acetamido-4-phenylpiperidin-1-yl)methyl]-1-(3,4-dichlorophenyl)-N-methyl-N-[(2-methylphenyl)methyl]cyclopropane-1-carboxamide
   Show/Hide
C33H37Cl2N3O2
 1
1
Ki = 5.3 nM
   TI
   LI
   LO
   TS
CP0399281
(1S,2R)-N-benzyl-1-(3,4-dichlorophenyl)-N-methyl-2-((4-(3-methylureido)-4-phenylpiperidin-1-yl)methyl)cyclopropanecarboxamide
   Show/Hide
C32H36Cl2N4O2
 1
1
Ki = 5.6 nM
   TI
   LI
   LO
   TS
CP0378685
(1S,2R)-1-(3,4-dichlorophenyl)-N-(4-fluorobenzyl)-N-methyl-2-((4-(pyrrolidin-1-ylsulfonyl)piperazin-1-yl)methyl)cyclopropanecarboxamide
   Show/Hide
C27H33Cl2FN4O3S
 1
1
Ki = 5.8 nM
   TI
   LI
   LO
   TS
CP0513051
(1S,2R)-2-((4-acetamido-4-phenylpiperidin-1-yl)methyl)-1-(3,4-dichlorophenyl)-N-(4-fluorobenzyl)-N-methylcyclopropanecarboxamide
   Show/Hide
C32H34Cl2FN3O2
 1
1
Ki = 5.8 nM
   TI
   LI
   LO
   TS
CP0057704
(1S,2R)-2-((4-acetamido-4-phenylpiperidin-1-yl)methyl)-N-benzyl-1-(3,4-dichlorophenyl)-N-methylcyclopropanecarboxamide
   Show/Hide
C32H35Cl2N3O2
 1
1
Ki = 5.9 nM
   TI
   LI
   LO
   TS
CP0498914
2-[(4-acetamido-4-phenylpiperidin-1-yl)methyl]-1-(3,4-dichlorophenyl)-N-[(2,4-dimethoxyphenyl)methyl]-N-methylcyclopropane-1-carboxamide
   Show/Hide
C34H39Cl2N3O4
 1
1
Ki = 5.9 nM
   TI
   LI
   LO
   TS
CP0409511
(1S,2R)-N-benzyl-1-(3,4-dichlorophenyl)-N-methyl-2-((4-phenyl-4-(piperidine-1-carbonyl)piperidin-1-yl)methyl)cyclopropanecarboxamide
   Show/Hide
C36H41Cl2N3O2
 1
1
Ki = 6.1 nM
   TI
   LI
   LO
   TS
CP0409512
(1S,2R)-1-(3,4-dichlorophenyl)-N-(4-fluorobenzyl)-N-methyl-2-((4-(2-(piperidin-1-yl)acetyl)piperazin-1-yl)methyl)cyclopropanecarboxamide
   Show/Hide
C30H37Cl2FN4O2
 1
1
Ki = 7.3 nM
   TI
   LI
   LO
   TS
CP0498916
(1S,2R)-2-((4-acetamido-4-phenylpiperidin-1-yl)methyl)-1-(3,4-dimethylphenyl)-N-(4-fluorobenzyl)-N-methylcyclopropanecarboxamide
   Show/Hide
C34H40FN3O2
 1
1
Ki = 7.3 nM
   TI
   LI
   LO
   TS
CP0513052
2-[(4-acetamido-4-phenylpiperidin-1-yl)methyl]-1-(3,4-dichlorophenyl)-N-methyl-N-[(4-methylphenyl)methyl]cyclopropane-1-carboxamide
   Show/Hide
C33H37Cl2N3O2
 1
1
Ki = 7.5 nM
   TI
   LI
   LO
   TS
CP0051744
(1S,2R)-1-(3,4-dichlorophenyl)-2-((4-(N,N-dimethylsulfamoyl)piperazin-1-yl)methyl)-N-(4-fluorobenzyl)-N-methylcyclopropanecarboxamide
   Show/Hide
C25H31Cl2FN4O3S
 1
1
Ki = 7.6 nM
   TI
   LI
   LO
   TS
CP0489232
(1S,2R)-N-benzyl-1-(3,4-dichlorophenyl)-N-methyl-2-((4-(methylsulfonamido)-4-phenylpiperidin-1-yl)methyl)cyclopropanecarboxamide
   Show/Hide
C31H35Cl2N3O3S
 1
1
Ki = 7.8 nM
   TI
   LI
   LO
   TS
CP0381520
(1S,2R)-2-((4-(2-(azepan-1-yl)acetyl)piperazin-1-yl)methyl)-1-(3,4-dichlorophenyl)-N-(4-fluorobenzyl)-N-methylcyclopropanecarboxamide
   Show/Hide
C31H39Cl2FN4O2
 1
1
Ki = 8.7 nM
   TI
   LI
   LO
   TS
CP0543425
2-[(4-acetamido-4-phenylpiperidin-1-yl)methyl]-N-[(4-chlorophenyl)methyl]-1-(3,4-dichlorophenyl)-N-methylcyclopropane-1-carboxamide
   Show/Hide
C32H34Cl3N3O2
 1
1
Ki = 11 nM
   TI
   LI
   LO
   TS
CP0381516
2-[(4-acetamido-4-phenylpiperidin-1-yl)methyl]-1-(3,4-dichlorophenyl)-N-[(3-fluorophenyl)methyl]-N-methylcyclopropane-1-carboxamide
   Show/Hide
C32H34Cl2FN3O2
 1
1
Ki = 12 nM
   TI
   LI
   LO
   TS
CP0477713
(1S,2R)-1-(3,4-dichlorophenyl)-N-(4-fluorobenzyl)-N-methyl-2-((4-(2-(pyrrolidin-1-yl)acetyl)piperazin-1-yl)methyl)cyclopropanecarboxamide
   Show/Hide
C29H35Cl2FN4O2
 1
1
Ki = 12 nM
   TI
   LI
   LO
   TS
CP0512755
(1S,2R)-N-benzyl-1-(3,4-dichlorophenyl)-N-methyl-2-((4-phenyl-4-ureidopiperidin-1-yl)methyl)cyclopropanecarboxamide
   Show/Hide
C31H34Cl2N4O2
 1
1
Ki = 12 nM
   TI
   LI
   LO
   TS
CP0498913
2-[(4-acetamido-4-phenylpiperidin-1-yl)methyl]-1-(3,4-dichlorophenyl)-N-[(3,4-dichlorophenyl)methyl]-N-methylcyclopropane-1-carboxamide
   Show/Hide
C32H33Cl4N3O2
 1
1
Ki = 13 nM
   TI
   LI
   LO
   TS
CP0543424
2-[(4-acetamido-4-phenylpiperidin-1-yl)methyl]-1-(3,4-dichlorophenyl)-N-[(2-methoxyphenyl)methyl]-N-methylcyclopropane-1-carboxamide
   Show/Hide
C33H37Cl2N3O3
 1
1
Ki = 14 nM
   TI
   LI
   LO
   TS
CP0543427
2-[(4-acetamido-4-phenylpiperidin-1-yl)methyl]-1-(3,4-dichlorophenyl)-N-methyl-N-(thiophen-3-ylmethyl)cyclopropane-1-carboxamide
   Show/Hide
C30H33Cl2N3O2S
 1
1
Ki = 14 nM
   TI
   LI
   LO
   TS
CP0487295
2-[(4-acetamido-4-phenylpiperidin-1-yl)methyl]-1-(3,4-dichlorophenyl)-N-[(4-methoxyphenyl)methyl]-N-methylcyclopropane-1-carboxamide
   Show/Hide
C33H37Cl2N3O3
 1
1
Ki = 15 nM
   TI
   LI
   LO
   TS
CP0512722
2-[(4-acetamido-4-phenylpiperidin-1-yl)methyl]-1-(3,4-dichlorophenyl)-N-[(2,4-dichlorophenyl)methyl]-N-methylcyclopropane-1-carboxamide
   Show/Hide
C32H33Cl4N3O2
 1
1
Ki = 16 nM
   TI
   LI
   LO
   TS
CP0469075
(1S,2R)-1-(3,4-dichlorophenyl)-2-((4-(3-(dimethylamino)-3-oxopropyl)piperazin-1-yl)methyl)-N-(4-fluorobenzyl)-N-methylcyclopropanecarboxamide
   Show/Hide
C28H35Cl2FN4O2
 1
1
Ki = 17 nM
   TI
   LI
   LO
   TS
CP0465489
2-[(4-acetamido-4-phenylpiperidin-1-yl)methyl]-1-(3,4-dichlorophenyl)-N-[(2-fluorophenyl)methyl]-N-methylcyclopropane-1-carboxamide
   Show/Hide
C32H34Cl2FN3O2
 1
1
Ki = 18 nM
   TI
   LI
   LO
   TS
CP0487294
2-[(4-acetamido-4-phenylpiperidin-1-yl)methyl]-N-[(2-chlorophenyl)methyl]-1-(3,4-dichlorophenyl)-N-methylcyclopropane-1-carboxamide
   Show/Hide
C32H34Cl3N3O2
 1
1
Ki = 20 nM
   TI
   LI
   LO
   TS
CP0438299
2-[(4-acetamido-4-phenylpiperidin-1-yl)methyl]-1-(3,4-dichlorophenyl)-N-[(3,5-dichlorophenyl)methyl]-N-methylcyclopropane-1-carboxamide
   Show/Hide
C32H33Cl4N3O2
 1
1
Ki = 23 nM
   TI
   LI
   LO
   TS
CP0426333
2-[(4-acetamido-4-phenylpiperidin-1-yl)methyl]-N-[(3-chlorophenyl)methyl]-1-(3,4-dichlorophenyl)-N-methylcyclopropane-1-carboxamide
   Show/Hide
C32H34Cl3N3O2
 1
1
Ki = 24 nM
   TI
   LI
   LO
   TS
CP0489227
2-[(4-acetamido-4-phenylpiperidin-1-yl)methyl]-1-(3,4-dichlorophenyl)-N-[(2,3-dichlorophenyl)methyl]-N-methylcyclopropane-1-carboxamide
   Show/Hide
C32H33Cl4N3O2
 1
1
Ki = 24 nM
   TI
   LI
   LO
   TS
CP0487296
2-[(4-acetamido-4-phenylpiperidin-1-yl)methyl]-1-(3,4-dichlorophenyl)-N-methyl-N-[(4-methylsulfanylphenyl)methyl]cyclopropane-1-carboxamide
   Show/Hide
C33H37Cl2N3O2S
 1
1
Ki = 28 nM
   TI
   LI
   LO
   TS
CP0378058
(1S,2R)-2-((4-acetamido-4-phenylpiperidin-1-yl)methyl)-1-(3-chlorophenyl)-N-(4-fluorobenzyl)-N-methylcyclopropanecarboxamide
   Show/Hide
C32H35ClFN3O2
 1
1
Ki = 32 nM
   TI
   LI
   LO
   TS
CP0543426
2-[(4-acetamido-4-phenylpiperidin-1-yl)methyl]-1-(3,4-dichlorophenyl)-N-[(3,5-dimethoxyphenyl)methyl]-N-methylcyclopropane-1-carboxamide
   Show/Hide
C34H39Cl2N3O4
 1
1
Ki = 32 nM
   TI
   LI
   LO
   TS
CP0505785
2-[(4-acetamido-4-phenylpiperidin-1-yl)methyl]-1-(3,4-dichlorophenyl)-N-[(3-methoxyphenyl)methyl]-N-methylcyclopropane-1-carboxamide
   Show/Hide
C33H37Cl2N3O3
 1
1
Ki = 33 nM
   TI
   LI
   LO
   TS
CP0377247
(1S,2R)-2-((4-acetamido-4-phenylpiperidin-1-yl)methyl)-1-(4-chlorophenyl)-N-(4-fluorobenzyl)-N-methylcyclopropanecarboxamide
   Show/Hide
C32H35ClFN3O2
 1
1
Ki = 36 nM
   TI
   LI
   LO
   TS
CP0509374
(1S,2R)-2-((4-acetamido-4-phenylpiperidin-1-yl)methyl)-N-(4-fluorobenzyl)-N-methyl-1-p-tolylcyclopropanecarboxamide
   Show/Hide
C33H38FN3O2
 1
1
Ki = 37 nM
   TI
   LI
   LO
   TS
CP0381518
(1S,2R)-2-((4-acetamido-4-phenylpiperidin-1-yl)methyl)-N-(4-fluorobenzyl)-N-methyl-1-m-tolylcyclopropanecarboxamide
   Show/Hide
C33H38FN3O2
 1
1
Ki = 40 nM
   TI
   LI
   LO
   TS
CP0489229
(1S,2R)-2-((4-acetamido-4-phenylpiperidin-1-yl)methyl)-1-(3,4-difluorophenyl)-N-(4-fluorobenzyl)-N-methylcyclopropanecarboxamide
   Show/Hide
C32H34F3N3O2
 1
1
Ki = 47 nM
   TI
   LI
   LO
   TS
CP0489225
2-[(4-acetamido-4-phenylpiperidin-1-yl)methyl]-1-(3,4-dichlorophenyl)-N-methyl-N-[[3-(trifluoromethyl)phenyl]methyl]cyclopropane-1-carboxamide
   Show/Hide
C33H34Cl2F3N3O2
 1
1
Ki = 50 nM
   TI
   LI
   LO
   TS
CP0404959
(1S,2R)-2-((4-acetamido-4-phenylpiperidin-1-yl)methyl)-N-(4-fluorobenzyl)-1-(3-methoxyphenyl)-N-methylcyclopropanecarboxamide
   Show/Hide
C33H38FN3O3
 1
1
Ki = 56 nM
   TI
   LI
   LO
   TS
CP0487297
(1S,2R)-2-((4-acetamido-4-phenylpiperidin-1-yl)methyl)-N-(4-fluorobenzyl)-1-(4-fluorophenyl)-N-methylcyclopropanecarboxamide
   Show/Hide
C32H35F2N3O2
 1
1
Ki = 67 nM
   TI
   LI
   LO
   TS
CP0512723
2-[(4-acetamido-4-phenylpiperidin-1-yl)methyl]-1-(3,4-dichlorophenyl)-N-[(3,4-dimethoxyphenyl)methyl]-N-methylcyclopropane-1-carboxamide
   Show/Hide
C34H39Cl2N3O4
 1
1
Ki = 67 nM
   TI
   LI
   LO
   TS
CP0498915
2-[(4-acetamido-4-phenylpiperidin-1-yl)methyl]-1-(3,4-dichlorophenyl)-N-methyl-N-(thiophen-2-ylmethyl)cyclopropane-1-carboxamide
   Show/Hide
C30H33Cl2N3O2S
 1
1
Ki = 70 nM
   TI
   LI
   LO
   TS
CP0505784
(1R,2S)-2-((4-acetamido-4-phenylpiperidin-1-yl)methyl)-N-benzyl-1-(3,4-dichlorophenyl)-N-methylcyclopropanecarboxamide
   Show/Hide
C32H35Cl2N3O2
 1
1
Ki = 83 nM
   TI
   LI
   LO
   TS
CP0489231
(1S,2R)-2-((4-acetamido-4-phenylpiperidin-1-yl)methyl)-1-(3,5-dichlorophenyl)-N-(4-fluorobenzyl)-N-methylcyclopropanecarboxamide
   Show/Hide
C32H34Cl2FN3O2
 1
1
Ki = 90 nM
   TI
   LI
   LO
   TS
CP0409510
(1S,2R)-2-((4-acetamido-4-phenylpiperidin-1-yl)methyl)-N-(4-fluorobenzyl)-N-methyl-1-(thiophen-2-yl)cyclopropanecarboxamide
   Show/Hide
C30H34FN3O2S
 1
1
Ki = 93 nM
   TI
   LI
   LO
   TS
CP0477712
(1S,2R)-2-((4-acetamido-4-phenylpiperidin-1-yl)methyl)-N-(4-fluorobenzyl)-N-methyl-1-(thiophen-3-yl)cyclopropanecarboxamide
   Show/Hide
C30H34FN3O2S
 1
1
Ki = 110 nM
   TI
   LI
   LO
   TS
CP0377248
(1S,2R)-2-((4-acetamido-4-phenylpiperidin-1-yl)methyl)-N-(4-fluorobenzyl)-1-(3-fluorophenyl)-N-methylcyclopropanecarboxamide
   Show/Hide
C32H35F2N3O2
 1
1
Ki = 140 nM
   TI
   LI
   LO
   TS
CP0438302
(1S,2R)-2-((4-acetamido-4-phenylpiperidin-1-yl)methyl)-1-(benzo[d][1,3]dioxol-5-yl)-N-(4-fluorobenzyl)-N-methylcyclopropanecarboxamide
   Show/Hide
C33H36FN3O4
 1
1
Ki = 140 nM
   TI
   LI
   LO
   TS
CP0509349
(1S,2R)-1-(3,4-dichlorophenyl)-N-(4-fluorobenzyl)-2-((isopropylamino)methyl)-N-methylcyclopropanecarboxamide
   Show/Hide
C22H25Cl2FN2O
 1
1
Ki = 140 nM
   TI
   LI
   LO
   TS
CP0498919
(1S,2R)-1-(3,4-dichlorophenyl)-N-(4-fluorobenzyl)-N-methyl-2-((propylamino)methyl)cyclopropanecarboxamide
   Show/Hide
C22H25Cl2FN2O
 1
1
Ki = 150 nM
   TI
   LI
   LO
   TS
CP0469074
(1S,2R)-2-((4-acetamido-4-phenylpiperidin-1-yl)methyl)-N-(4-fluorobenzyl)-N-methyl-1-(3-(trifluoromethyl)phenyl)cyclopropanecarboxamide
   Show/Hide
C33H35F4N3O2
 1
1
Ki = 210 nM
   TI
   LI
   LO
   TS
CP0489228
(1S,2R)-2-((4-acetamido-4-phenylpiperidin-1-yl)methyl)-1-(4-cyanophenyl)-N-(4-fluorobenzyl)-N-methylcyclopropanecarboxamide
   Show/Hide
C33H35FN4O2
 1
1
Ki = 270 nM
   TI
   LI
   LO
   TS
CP0438301
(1S,2R)-2-((4-acetamido-4-phenylpiperidin-1-yl)methyl)-N-(4-fluorobenzyl)-1-(4-methoxyphenyl)-N-methylcyclopropanecarboxamide
   Show/Hide
C33H38FN3O3
 1
1
Ki = 350 nM
   TI
   LI
   LO
   TS
CP0513053
(1S,2R)-2-((4-acetamido-4-phenylpiperidin-1-yl)methyl)-N-(4-fluorobenzyl)-N-methyl-1-(4-(trifluoromethyl)phenyl)cyclopropanecarboxamide
   Show/Hide
C33H35F4N3O2
 1
1
Ki = 1000 nM
   TI
   LI
   LO
   TS
CP0409508
(1S,2R)-2-((4-acetamido-4-phenylpiperidin-1-yl)methyl)-1-(3-cyanophenyl)-N-(4-fluorobenzyl)-N-methylcyclopropanecarboxamide
   Show/Hide
C33H35FN4O2
 1
1
Ki = 1900 nM
   TI
   LI
   LO
   TS
Biochemical Assays
Compound ID Compound Name Compound Formula
CP0058365
methyl N-[(3-methoxy-2-phenylquinoline-4-carbonyl)amino]-N-phenylcarbamate
   Show/Hide
C25H21N3O4
 1
1 IC50 = 4.5 nM
CP0044631
(S)-3-methyl-2-phenyl-N-(1-phenylpropyl)quinoline-4-carboxamide
   Show/Hide
C26H24N2O
 6
1 IC50 = 7.1 nM
2 IC50 = 8.8 nM
3 IC50 = 15 nM
4 Ki = 3.8 nM
5 Ki = 7.943 nM
6 Ki = 8.3 nM
CP0290288
tert-butyl N-[(2S)-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-1-oxo-3-phenylpropan-2-yl]carbamate
   Show/Hide
C23H29N3O4
 1
1 IC50 = 1600 nM
CP0117145
tert-butyl N-[(2S)-1-[[(2S)-1-amino-1-oxo-3-phenylpropan-2-yl]amino]-3-(1H-indol-3-yl)-1-oxopropan-2-yl]carbamate
   Show/Hide
C25H30N4O4
 1
1 IC50 = 3000 nM
CP0074738
(S)-(+)-N-((3-[1-Benzoyl-3-(3,4-dichlorophenyl)piperidin-3-yl]prop-1-yl)-4-phenylpiperidin-4-yl)-N-methylacetamine
   Show/Hide
C35H41Cl2N3O2
 2
1 Ki = 0.1995 nM
2 Ki = 1.9 nM
CP0204318
(5S,8S,14S,17S,20S,23S,26S,29S,32S)-26-((1H-imidazol-5-yl)methyl)-32-amino-14,17,20-tribenzyl-5-carbamoyl-23-(carboxymethyl)-8-isobutyl-15-methyl-29-(2-(methylthio)ethyl)-7,10,13,16,19,22,25,28,31-nonaoxo-2-thia-6,9,12,15,18,21,24,27,30-nonaazatetratriacontan-34-oic acid
   Show/Hide
C60H81N13O14S2
 1
1 Ki = 0.3 nM
CP0074740
[(8R)-3-[2-(2,4-difluorophenyl)-1,3-thiazol-4-yl]-8-methyl-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-(4-thiophen-2-ylphenyl)methanone
   Show/Hide
C26H19F2N5OS2
 1
1 Ki = 1.995 nM
CP0282991
2-[3,5-bis(trifluoromethyl)phenyl]-N-[4-(4-fluoro-2-methylphenyl)-6-[(2R,3S)-3-hydroxy-2-(hydroxymethyl)pyrrolidin-1-yl]pyridin-3-yl]-N,2-dimethylpropanamide
   Show/Hide
C30H30F7N3O3
 1
1 Ki = 2.9 nM
CP0114969
[(8R)-8-methyl-3-(3-methyl-1,2,4-thiadiazol-5-yl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-(4-thiophen-2-ylphenyl)methanone
   Show/Hide
C20H18N6OS2
 1
1 Ki = 3.162 nM
CP0114970
(S)-(-)-N-(R-ethylbenzyl)-3-hydroxy-2-phenylquinoline-4-carboxamide
   Show/Hide
C25H22N2O2
 1
1 Ki = 7.4 nM
CP0126344
(4-fluorophenyl)-[(8R)-8-methyl-3-[3-(trifluoromethyl)-1,2,4-thiadiazol-5-yl]-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]methanone
   Show/Hide
C16H12F4N6OS
 1
1 Ki = 7.943 nM
CP0088854
[(8R)-8-methyl-3-(2-methyl-1,3-thiazol-4-yl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-(4-thiophen-2-ylphenyl)methanone
   Show/Hide
C21H19N5OS2
 1
1 Ki = 12.59 nM
CP0212153
(4-chlorophenyl)-[(8R)-8-methyl-3-(3-methyl-1,2,4-thiadiazol-5-yl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]methanone
   Show/Hide
C16H15ClN6OS
 1
1 Ki = 19.95 nM
CP0112422
(4-fluorophenyl)-[(8R)-8-methyl-3-(3-methyl-1,2,4-thiadiazol-5-yl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]methanone
   Show/Hide
C16H15FN6OS
 1
1 Ki = 25.12 nM
CP0126339
(4-fluorophenyl)-[(8R)-8-methyl-3-(3-propan-2-yl-1,2,4-oxadiazol-5-yl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]methanone
   Show/Hide
C18H19FN6O2
 1
1 Ki = 25.12 nM
CP0126108
(4-fluorophenyl)-[(8R)-8-(2-hydroxyethyl)-3-(3-methyl-1,2,4-thiadiazol-5-yl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]methanone
   Show/Hide
C17H17FN6O2S
 1
1 Ki = 31.62 nM
CP0147959
[(8R)-8-methyl-3-(3-methyl-1,2,4-thiadiazol-5-yl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-phenylmethanone
   Show/Hide
C16H16N6OS
 1
1 Ki = 50.12 nM
CP0215350
(4-fluorophenyl)-[3-(3-methyl-1,2,4-thiadiazol-5-yl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]methanone
   Show/Hide
C15H13FN6OS
 1
1 Ki = 100 nM
CP0120396
(4-fluorophenyl)-[(8R)-8-methyl-3-(3-methyl-1,2,4-oxadiazol-5-yl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]methanone
   Show/Hide
C16H15FN6O2
 1
1 Ki = 125.89 nM
CP0220343
[8,8-dimethyl-3-(3-methyl-1,2,4-thiadiazol-5-yl)-5,6-dihydro-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]-(4-fluorophenyl)methanone
   Show/Hide
C17H17FN6OS
 1
1 Ki = 199.53 nM
CP0142900
(5-(4-chlorophenyl)-1-methyl-1H-pyrazol-3-yl)(4-(2-methoxyphenyl)piperazin-1-yl)methanone
   Show/Hide
C22H23ClN4O2
 1
1 Ki = 370 nM
CP0142901
(3-(4-chlorophenyl)-1-methyl-1H-pyrazol-5-yl)(4-(2-methoxyphenyl)piperazin-1-yl)methanone
   Show/Hide
C22H23ClN4O2
 1
1 Ki = 540 nM
CP0064950
(4-fluorophenyl)-[(8R)-8-methyl-3-(1,2,4-thiadiazol-5-yl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]methanone
   Show/Hide
C15H13FN6OS
 1
1 Ki = 1258.93 nM
CP0326360
(2S)-N-[(4-chlorophenyl)methyl]-2-(3,4-dichlorophenyl)-4-(6-fluoro-1-methyl-2-oxospiro[3,1-benzoxazine-4,4'-piperidine]-1'-yl)-N-methylbutanamide
   Show/Hide
C31H31Cl3FN3O3
 1
1 Ki = 3981.07 nM
CP0247643
4-[4-[acetyl(propyl)amino]piperidin-1-yl]-2-(3,4-dichlorophenyl)-N-[(1R)-1-(4-fluorophenyl)-2-hydroxyethyl]-2-methylbutanamide
   Show/Hide
C29H38Cl2FN3O3
 1
1 Ki = 5011.87 nM
CP0120399
(4-fluorophenyl)-[(8R)-8-methyl-3-(5-methyl-1,3,4-thiadiazol-2-yl)-6,8-dihydro-5H-[1,2,4]triazolo[4,3-a]pyrazin-7-yl]methanone
   Show/Hide
C16H15FN6OS
 1
1 Ki = 10000 nM
Clinical Information about the Protein
Target 1 ( Neuromedin-K receptor (TACR3) )
Target Type Successful Target
Disease 6 Target-related Diseases  6
1 Hot flushes [ICD-11: GA30]
2 Ischemic stroke [ICD-11: 8B11.5Z]
3 Schizoaffective disorder [ICD-11: 6A21]
4 Multiple sclerosis [ICD-11: 8A40]
5 Schizophrenia [ICD-11: 6A20]
6 Asthma [ICD-11: CA23]
Approved Drug(s) 1 Approved Drug  1
1 Fezolinetant Approved
Hot flushes
Clinical Trial Drug(s) 3 Clinical Trial Drugs  3
1 Senktide Phase 2
Ischemic stroke
2 AZD2624 Phase 2
Multiple sclerosis
3 Talnetant Phase 2
Schizophrenia
Discontinued Drug(s) 1 Discontinued Drug  1
1 Osanetant Discontinued in Phase 2b
Schizoaffective disorder
Investigative Drug(s) 1 Investigative Drug  1
1 GSK-172981 Investigative
Asthma
Preclinical Drug(s) 1 Preclinical Drug  1
1 SB222200 Preclinical
Schizoaffective disorder
Similar Protein(s) and Bioactivity Statistics
50% Identity
Protein ID Protein Name Protein Organism
PT04126 Neuromedin-K receptor Rattus norvegicus, Rat